Hyderabad: A brain tumour diagnosis often triggers fear — not just from the disease but from the invasive treatments that ...

Dr. Reddy's faces revenue slowdown post gRevlimid boost, but new investments and partnerships offer long-term growth ...

Doctors in Hyderabad raise awareness on rising brain tumour cases, emphasizing early detection, prompt treatment, and advancing medical interventions.

Andhra Pradesh CM N. Chandrababu Naidu congratulated Vadlamudi Lokesh of Vijayawada Narayana College for achieving AIR 10 in ...

Dr. Reddy's Laboratories Ltd has generally positive cash flows and an excellent current ratio of 2.58. Additionally, the ...

Dr. Reddy's Labs ADR saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 0% to 16%.

Dr. Crystal Truong and Dr. Vish Reddy opened the doors to Apex Eye in Frisco with a clear mission to create an ophthalmology ...

Ontario, Calif.-based Prime Healthcare realigned services at Illinois hospitals it recently acquired from St. Louis-based Ascension, citing unsustainable financial losses and low patient volumes that ...

Dr. Reddy's Laboratories Ltd. closed 7.02% short of its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Dr. Reddy’s Laboratories has partnered with global biotech firm Alvotech to co-develop and commercialize a biosimilar of ...

Dr. Reddy's Laboratories Ltd marked a 5.4% change today, compared to -0.0% for the S&P 500. Is it a good value at today's ...

Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.